Expression, function and endogenous modulators of the transient receptor potential (TRP) channels TRPV1, TRPV4, TRPM8 und TRPA1 in human corneal endothelial cells
Expression, function and endogenous modulators of the transient receptor potential (TRP) channels TRPV1, TRPV4, TRPM8 und TRPA1 in human corneal endothelial cells
批准号:
288923337
负责人:
Privatdozent Dr. Stefan Mergler
金额:
$0.0万
依托单位:
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
2015
资助国家:
德国
项目状态:
已结题
起止时间:
2014-12-31 至 2017-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The human corneal endothelium (HCE) fulfills various required functions mandatory for the maintenance of corneal transparency and normal vision. These functions are dependent on cellular mechanisms that mediate regulation of intracellular calcium levels. Transient receptor potential channels (TRPs) play a substantial role in this process. Recent studies showed that functional TRP channel subtype activity of TRPV1 and TRPM8 modulate apoptosis (calcium-apoptosis link). Therefore, further studies are warranted to determine how modulation of these TRP subtypes contributes to the support of HCE function. In recent studies, the applicants also demonstrated for the first time that HCE cells express other TRP subtypes that include TRPV4 as well as TRPA1. Current investigations confirmed functional expression of TRPM8 and TRPA1 also in primary HCE cell cultures. Furthermore, our results indicate that these TRPs play a role in the temperature-dependent and osmosensitive regulation of intracellular calcium concentration. The aim of this project is to determine the properties of TRPs in regulating corneal endothelial-relevant biological processes and to identify endogenous TRP channel activity modulators, using highly sensitive methods (Ca2+ imaging, patch-clamp, qPCR). In the established in vitro HCEC-12 cell model and fresh and cultured primary HCE cell cultures, we plan to delineate the molecular, functional and pharmacological properties of TRPs as well as their linked signaling pathways, which mediate control of responses that are essential for tissue viability. In addition, we will define mechanisms of functional cross-talk between TRPV1, TRPV4, TRPM8 and TRPA1 and the HCE-relevant membrane cognate receptors for EGF and FGF-2 in the HCE. Furthermore, the impact of long-term exposure to ophthalmic drugs on TRP channel function and regulation and its implication on corneal endothelial function will be investigated. Overall, the results of this study will contribute to a better understanding of HCE biology and hold promise to develop novel strategies for prolonging and improving corneal endothelial cell function before and after keratoplasty and possibly also during long-term exposure to clinically proven effective ophthalmological medications.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
DOI:
10.3389/fendo.2018.00670
发表时间:
2018-11
期刊:
Frontiers in Endocrinology
影响因子:
5.2
作者:
[Ersal Türker;F. Garreis;N. Khajavi;P. Reinach;P. Joshi;T. Brockmann;Alexander Lucius;Nina Ljubojevic;Elizabeth Turan;D. Cooper;F. Schick;Rob Reinholz;U. Pleyer;J. Köhrle;S. Mergler]
通讯作者:
Ersal Türker;F. Garreis;N. Khajavi;P. Reinach;P. Joshi;T. Brockmann;Alexander Lucius;Nina Ljubojevic;Elizabeth Turan;D. Cooper;F. Schick;Rob Reinholz;U. Pleyer;J. Köhrle;S. Mergler
国内基金
海外基金
登录
查看更多内容
PRNP调控巨噬细胞M2极化并减弱吞噬功能促进子宫内膜异位症进展的机制研究
-
批准号:82371651
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:赵栋
-
依托单位:
CBP/p300-HADH轴在基础胰岛素分泌调节中的作用和机制研究
-
批准号:82370798
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:王晓
-
依托单位:
配子生成素GGN不同位点突变损伤分子伴侣BIP及HSP90B1功能导致精子形成障碍的发病机理
-
批准号:82371616
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:姚晨成
-
依托单位:
基于再生运动神经路径优化Agrin作用促进损伤神经靶向投射的功能研究
-
批准号:82371373
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:沃雁
-
依托单位:
Idh3a作为线粒体代谢—表观遗传检查点调控产热脂肪功能的机制研究
-
批准号:82370851
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:包玉倩
-
依托单位:
PROCR信号通路介导的血管新生在卵巢组织移植中的作用及机制研究
-
批准号:82371726
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2023
-
负责人:李文
-
依托单位:
G蛋白偶联受体GPR110调控Lp-PLA2抑制非酒精性脂肪性肝炎的作用及机制研究
-
批准号:82370865
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:黄哲
-
依托单位:
GASP-1通过Myostatin信号通路调控颏舌肌功能的作用及机制研究
-
批准号:82371131
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:易红良
-
依托单位:
双硫仑结合并抑制谷氨酸脱氢酶1活性调节Th17/Treg细胞平衡的作用与机制探究
-
批准号:82371755
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:王秦兰
-
依托单位:
犬尿氨酸酶KYNU参与非酒精性脂肪肝进展为肝纤维化的作用和机制研究
-
批准号:82370874
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:刘才智
-
依托单位: